Table 2.
Baseline laboratory data of study patients.
| Variables | Total | 7-Day Mortality | 7-Day Survivors | p Value |
|---|---|---|---|---|
| (n = 240, 100%) | (n = 130, 54.2%) | (n = 110, 45.8%) | ||
| WBC (103/µL) | 13.1 ± 12.3 | 14.1 ± 15.5 | 11.9 ± 7.1 | 0.147 |
| Hemoglobin (g/dL) | 9.4 ± 2.1 | 9.5 ± 2.3 | 9.4 ± 1.9 | 0.892 |
| Platelet (103/µL) | 127.8 ± 86.5 | 127.9 ± 89.1 | 127.6 ± 83.8 | 0.980 |
| Sodium (mEq/L) | 138.9 ± 7.3 | 139.6 ± 7.9 | 138.1 ± 6.4 | 0.119 |
| Potassium (mEq/L) | 4.5 ± 1.0 | 4.6 ± 1.0 | 4.5 ± 0.9 | 0.289 |
| Calcium (mg/dL) | 7.8 ± 1.3 | 7.7 ± 1.2 | 7.8 ± 1.4 | 0.669 |
| Phosphate (mg/dL) | 5.5 ± 2.9 | 5.9 ± 3.2 | 5.0 ± 2.5 | 0.021 |
| Bilirubin, total (mg/dL) | 2.8 ± 4.9 | 2.9 ± 4.9 | 2.6 ± 4.8 | 0.568 |
| AST (IU/L) | 401.8 ± 1157.2 | 416.8 ± 1012.7 | 384.5 ± 1308.8 | 0.831 |
| ALT (IU/L) | 185.8 ± 575.5 | 199.1 ± 473.4 | 170.6 ± 675.7 | 0.706 |
| eGFR (ml/min/1.73 m2) | 22.7 ± 17.1 | 23.7 ± 16.2 | 21.4 ± 18.1 | 0.300 |
| pH | 7.29 ± 0.13 | 7.25 ± 0.12 | 7.33 ± 0.12 | <0.001 |
| pH < 0.35, n (%) | 164 (68.3) | 107 (82.3) | 57 (51.8) | <0.001 |
| BE (mmol/L) | −7.75 ± 7.10 | −8.88 ± 6.64 | −6.43 ± 7.43 | 0.008 |
| PaO2/FiO2 < 300 | 188 (78.3) | 106 (81.5) | 82 (74.5) | 0.125 |
Data are presented as mean ± standard deviation or number (%). Abbreviations: WBC, whole blood cell; AST, aspartate aminotransferase; ALT, alanine aminotransferase; eGFR, estimated glomerular filtration rate; BE, base excess.